Andere Sprachen Arcus Biosciences, Inc.

Aktien

A2JGDZ

US03969F1093

RCUS

Markt geschlossen - Nyse Andere Börsenplätze 22:00:02 23.05.2024			% 5 Tage	% 1. Jan.
16,28 ^USD	-2,81 %		-6,76 %	-14,76 %

16.05.	Transcript : Arcus Biosciences, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
08.05.	Transcript : Arcus Biosciences, Inc., Q1 2024 Earnings Call, May 08, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ARC-9: A Randomized Study to Evaluate Etrumadenant Based Treatment Combinations in Previously Treated Metastatic Colorectal Cancer (mCRC) - Form 8-K	23.05.
Arcus Biosciences Announces New Employment Inducement Grants	09.05.
Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q1 Revenue $145M	08.05.
Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q1 Revenue $145M	08.05.
Arcus Biosciences Reports First-Quarter 2024 Financial Results and Provides a Pipeline Update	08.05.
Arcus Biosciences, Inc. Reports Impairment of Long-Lived Assets for the First Quarter Ended March 31, 2024	08.05.
Arcus Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	08.05.
Arcus Biosciences to Participate in the Bank of America Healthcare Conference 2024	02.05.
Arcus Biosciences to Present New Data from Phase 2 Studies of Novel Immuno-Oncology Combinations at the 2024 ASCO Annual Meeting	24.04.
Arcus Biosciences to Host Conference Call to Discuss First-Quarter 2024 Financial Results and Pipeline Update	23.04.
Arcus Biosciences Announces New Employment Inducement Grants	09.04.
Arcus Biosciences Announces New Employment Inducement Grants	26.03.
Arcus Biosciences Announces New Employment Inducement Grants	11.03.
Arcus Biosciences Insider Sold Shares Worth $1,177,967, According to a Recent SEC Filing	29.02.
Arcus Biosciences Insider Sold Shares Worth $543,187, According to a Recent SEC Filing	29.02.
Arcus Biosciences to Participate in Two Upcoming Investor Conferences	28.02.
Arcus Biosciences Announces New Employment Inducement Grants	27.02.
Earnings Flash (RCUS) ARCUS BIOSCIENCES Reports Q4 Revenue $31M	21.02.
Arcus Biosciences Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides a Pipeline Update	21.02.
Arcus Biosciences, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	21.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Arcus Biosciences, Inc.

Aktien

A2JGDZ

US03969F1093

RCUS

Andere Sprachen

Filter